meetings

Transcript, Meeting 12 Session 1

DR. GUTMANN:  Welcome, everybody. I'm Amy Gutmann.  I'm President of the University of Pennsylvania and Chair of the Presidential Commission for the Study of Bioethical Issues. On behalf of myself and our Vice Chair, James Wagner, the President of Emory University, I'd like to welcome you to our 12th meeting.

Date

Mon, 01/14/2013

Transcript, Meeting 11, Session 3

SESSION 3: MCM USE AND RESEARCH IN A POST-EVENT SCENARIO

DR. WAGNER:  So, let’s get started. 

We are shifting now from, um, uh, pre-event discussions to post event.  MCM use, medical countermeasures use and research and post-event scenarios, and we will again, the format, we’ll ask each of you to make your presentations, and then open it for questions.

Date

Mon, 11/05/2012

Transcript, Meeting 11, Session 7

SESSION 7: MEMBER DISCUSSION

DR. GUTMANN:  Welcome back everybody.  We have until 11:45, right?  Great.  So, we'll take an hour and then wrap up. 

Date

Tue, 11/06/2012

Transcript, Meeting 11, Session 4

SESSION 4: ROUNDTABLE DISCUSSION

DR. WAGNER: We appreciate you all hanging around for a roundtable.  We have found these to be, uh, uh, very helpful, uh, although they tend to be extremely wide ranging and, uh, and I’m concerned that there isn’t – we try – in order to keep them from just going, spinning immediately out of control, we try to, uh, pose a framing question.  It’s very hard to pose a framing question for this one but, maybe we can start with something like this.

Date

Mon, 11/05/2012

Pages

Subscribe to RSS - meetings

This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply